TY - JOUR
T1 - The politics of health mobilization in the United States
T2 - The promise and pitfalls of “disease constituencies”
AU - Epstein, Steven
N1 - Funding Information:
Funding to prepare this article was provided by the Robert Wood Johnson Foundation Contract #70890-027 , which bears no responsibility for the content. I am grateful to Michèle Lamont, Stefan Timmermans, and the anonymous reviewers for essential commentary on a previous draft. I would also like to thank Michèle Lamont, Mabel Berezin, Alonzo Plough, Matthew Trujillo, and other participants at the RWJF Meeting of Cultural Sociologists on May 29, 2014, for helpful suggestions on preliminary work that led to this article.
Funding Information:
By studying activism that is sparked by an imminent disease threat, what lessons can be gleaned for projects that seek to forge connections across differences and mobilize individuals who may not live under the shadow of a particular disease? At first glance, disease-based activism almost necessarily pits advocates of specific illnesses against one another as they vie for attention and their “piece of the pie” in the form of funding allocations from Congress and research grants from the National Institutes of Health (NIH) ( Best, 2012 ). As suggested by a recent news article in Science called “What Does a Disease Deserve?” ( Kaiser, 2015 ), debates about illness-specific activism—especially in the United States—tend to position the various distinct patient groups as engaged in competition that is inevitably zero-sum. Furthermore, it is plausible to argue that a narrowed focus and singular mission is precisely what permits such groups to mobilize effectively, establish a coherent collective identity, and frame their agendas in ways that resonate. Thus the disease-based model of mobilization seems immediately to raise legitimate doubts about the prospects for opening up broader conversations, not only among those who confront different health challenges, but also between those who are healthy and those who are well.
Publisher Copyright:
© 2016 Elsevier Ltd
PY - 2016/9/1
Y1 - 2016/9/1
N2 - A critical review of recent literature on U.S. social movements concerned with matters of health and illness prompts reconsideration of the prevailing conception of such movements as necessarily isolated and particularistic. With a focus on disease-constituency-based mobilization—presently the most potent model of efficacious activism to be found in the domain of health and illness in the United States—I argue that such activism may tend in two directions: a specific response to an imminent disease threat, and a bridging of collective action frames and identities that can lead to connections across differences and broader mobilization. Case studies have demonstrated how patient activism has affected the management of illness, attitudes and practices of health professionals, research practices, processes of innovation, state policies, and corporate behavior. Through close analysis of patient group mobilization and its distinctive orientation toward knowledge and expertise, I argue that patient groups in practice may connect with or influence one another or a range of other forms of mobilization in relation to health, and I examine the “linkage mechanisms”—spillover, coalition, and frame amplification—by which this can occur. Rather than imagine a stark opposition between particularistic, single-issue health politics, on the one hand, and universalistic efforts to transform the meaning and practice of health and health care in the United States, on the other, I propose closer attention to the potentially Janus-faced character of many health movement organizations and the ways in which they may look either inward or outward.
AB - A critical review of recent literature on U.S. social movements concerned with matters of health and illness prompts reconsideration of the prevailing conception of such movements as necessarily isolated and particularistic. With a focus on disease-constituency-based mobilization—presently the most potent model of efficacious activism to be found in the domain of health and illness in the United States—I argue that such activism may tend in two directions: a specific response to an imminent disease threat, and a bridging of collective action frames and identities that can lead to connections across differences and broader mobilization. Case studies have demonstrated how patient activism has affected the management of illness, attitudes and practices of health professionals, research practices, processes of innovation, state policies, and corporate behavior. Through close analysis of patient group mobilization and its distinctive orientation toward knowledge and expertise, I argue that patient groups in practice may connect with or influence one another or a range of other forms of mobilization in relation to health, and I examine the “linkage mechanisms”—spillover, coalition, and frame amplification—by which this can occur. Rather than imagine a stark opposition between particularistic, single-issue health politics, on the one hand, and universalistic efforts to transform the meaning and practice of health and health care in the United States, on the other, I propose closer attention to the potentially Janus-faced character of many health movement organizations and the ways in which they may look either inward or outward.
KW - Biocitizenship
KW - Coalitions
KW - Expertise
KW - Frame alignment
KW - Patient groups
KW - Social movements
KW - Spillover
KW - United States
UR - http://www.scopus.com/inward/record.url?scp=84989360828&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84989360828&partnerID=8YFLogxK
U2 - 10.1016/j.socscimed.2016.01.048
DO - 10.1016/j.socscimed.2016.01.048
M3 - Article
C2 - 26857786
AN - SCOPUS:84989360828
SN - 0277-9536
VL - 165
SP - 246
EP - 254
JO - Ethics in Science and Medicine
JF - Ethics in Science and Medicine
ER -